Evaluation of the Effectiveness of PREVENIR (PREVention ENvIronnement Reproduction) Platforms
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
Unblinded randomized clinical superiority trial in two parallel groups (intervention vs. no intervention) national multicentre to evaluate the effectiveness of the platforms on the evolution of phenoxyacetic acid levels measured in the urine at inclusion and 3 months after the intervention for patients who received the intervention compared to patients who did not receive the intervention.
Eligibility criteria
Qualifiers
All pregnant women less than 24 SA of age referred to the PREVENIR platforms participating in the study for management.
Only women less than 24 SA months pregnant will be included to limit the number of women who gave birth during the study.
More than 18 years old
Professionnal working within PREVENIR platforms
Disqualifiers
Women under court protection, under guardianship or curatorship, severely altered physical and/or psychological health, which, in the opinion of the investigator, may affect the participant's compliance to the study.
Women with an altered medical condition related to prgnancy that may required a therapeutic abortion according to the environmental expert
Non-French speakers
Trial design
Treatments tested in this trial
- protocolized interview and prevention messages
Treatment groups
300 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov